Talreja Hari, Ryan Stephen Edward, Graham Janet, Sood Manish M, Hadziomerovic Adnan, Clark Edward, Hiremath Swapnil
Division of Nephrology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Department of Medical Imaging, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
PLoS One. 2017 Mar 27;12(3):e0174061. doi: 10.1371/journal.pone.0174061. eCollection 2017.
With the increasing frequency of tunneled hemodialysis catheter use there is a parallel increase in the need for removal and/or exchange. A small but significant minority of catheters become embedded or 'stuck' and cannot be removed by traditional means. Management of embedded catheters involves cutting the catheter, burying the retained fragment with a subsequent increased risk of infections and thrombosis. Endoluminal dilatation may provide a potential safe and effective technique for removing embedded catheters, however, to date, there is a paucity of data.
All patients with endoluminal dilatation for embedded catheters at our institution since Jan. 2010 were included. Patients who had an embedded catheter were matched 1:3 with patients with uncomplicated catheter removal. Baseline patient and catheter characteristics were compared. Outcomes included procedural success and procedure-related infection. Logistic regression models were used to determine factors associated with embedded catheters.
We matched 15 cases of embedded tunneled catheters with 45 controls. Among patients with embedded catheters, there were no complications with endoluminal dilatation. Factors independently associated with embedded catheters included catheter dwell time (> 2 years) and history of central venous stenosis.
Embedded catheters can be successfully managed by endoluminal dilatation with minimal complications and factors associated with embedding include dwell times > 2 years and/or with a history of central venous stenosis.
随着隧道式血液透析导管使用频率的增加,移除和/或更换的需求也相应增加。一小部分但数量可观的导管会发生嵌顿或“卡住”,无法通过传统方法移除。处理嵌顿导管需要切断导管,将残留片段埋入体内,这会增加感染和血栓形成的风险。腔内扩张术可能为移除嵌顿导管提供一种潜在的安全有效技术,然而,迄今为止,相关数据较少。
1)确定与导管嵌顿相关的因素;2)确定与腔内扩张术相关的结果。
纳入自2010年1月起在本机构接受腔内扩张术治疗嵌顿导管的所有患者。将有嵌顿导管的患者与导管顺利移除的患者按1:3进行匹配。比较患者和导管的基线特征。结果包括手术成功和与手术相关的感染。采用逻辑回归模型确定与嵌顿导管相关的因素。
我们将15例嵌顿的隧道式导管患者与45例对照进行了匹配。在嵌顿导管患者中,腔内扩张术无并发症发生。与嵌顿导管独立相关的因素包括导管留置时间(>2年)和中心静脉狭窄病史。
腔内扩张术可成功处理嵌顿导管,并发症极少,与导管嵌顿相关的因素包括留置时间>2年和/或有中心静脉狭窄病史。